IFNA1 and systemic lupus erythematosus: For example, in systemic lupus erythematosus (SLE), estrogen exacerbates the inflammatory response by targeting key immune pathways, including type 1 interferon (IFN) responses, differentiation of CD4+ T helper cells, and survival of self-reactive B cells [62].